Extended Data Fig. 3: Selection of intrahepatic portal and central zones.
From: iHALT unlocks liver functionality as a surrogate secondary lymphoid organ
(A, B) Portal and central zones used for quantification of various transcripts (Extended Data Fig. 4) were selected based on expression of various zone-specific transcripts, such as Hal (portal) and Cyp2e1 (central) at week 1 post-infection with either (A) RHV or (B) LCMV clone 13 infection.
